Dr. Peter Hui Jin, MD

Dr. Jin practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Jin's NPI, 1396144093, was assigned on August 19, 2014. Dr. Jin holds Maryland license D0087191.

Dr. Jin's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Jin's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Dr. Jin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jin practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Jin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Jin is licensed in Maryland.

CMS data shows 59 Medicare services from Dr. Jin across 3 procedure codes in 2024, for 65 Medicare patients. Medicare paid $4,057 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Jin in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jin's median patient age at 59, with 45% women.

In 2024, Dr. Jin wrote 253 Medicare Part D claims for 28 patients. 55% of them were for generic drugs. CMS names the drug for 205 of them, across 9 drugs with 11 or more claims each, at $994,417 in total drug cost. In 2023, CMS named 499 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Jin for performance year 2024, reported as part of a group. Dr. Jin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Jin, published from 2017 to 2023. 2019 was the busiest year, with 2. Dr. Jin has published most often in Neurology. Dr. Jin's most frequent co-authors are Susan C. Shin, MD, Mandip Singh Dhamoon, MD, MPH and Rachel B. Brandstadter, MD.

CMS Open Payments shows 2 general payments to Dr. Jin from 1 drug or device company from 2019 to 2021. Consulting fees make up the largest share, 98% of the total. Akcea Therapeutics, Inc. paid the most, $1,492.